CITIUS ONCOLOGY, INC.

SEC 4/A · Filed

0001213900-25-124530Accepted

Applies to the EDGAR acceptance time.

Other time zone

The original filing has not been identified with sufficient confidence.

Insider transactionsEvent date Sep 19, 2025

Grant, award or other acquisition by Mayersohn Joel David

Security
Common Stock
Code
A
Shares
300,000
Price per share
0.00
Structured facts
{
  "amendment_scope": "rows_as_filed",
  "code": "A",
  "date": "2025-09-19",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person\u0027s Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."
  },
  "owners": [
    {
      "cik": "0001588395",
      "name": "Mayersohn Joel David",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "321228",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "300000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}